Figure 2
Comparison of time to progression and overall survival between patients with TdT-positive versus TdT-negative T-ALL/LBL (a, b); and patients with T-ALL/LBL with or without an early T-precursor (ETP) phenotype (c, d).
Figure 2 | Modern Pathology
